Jonathan G. Pabalan
Publications by Year
Research Areas
Cancer, Lipids, and Metabolism, Metabolomics and Mass Spectrometry Studies, Peroxisome Proliferator-Activated Receptors, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways
Most-Cited Works
- → Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2011)275 cited
- → cDNA microarray reveals altered cytoskeletal gene expression in space‐flown leukemic T lymphocytes (Jurkat)(2001)115 cited
- → Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors(2016)27 cited
- → Pharmacodynamics‐based approach for efficacious human dose projection of BMS‐986260, a small molecule transforming growth factor beta receptor 1 inhibitor(2020)3 cited
- → Abstract C62: Cancer cell dependence on unsaturated fatty acids implicates stearoyl-coA desaturase as a target for cancer therapy(2011)3 cited
- → Abstract 5395: Anti-tumor activity of BMS-595, a novel CK2 kinase inhibitor(2015)1 cited
- → Supplementary Table 1 from Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2023)
- → Abstract 4115: Depletion of unsaturated fatty acids by stearoyl-coA desaturase inhibition results in endoplasmic reticulum stress-mediated tumor cell death(2012)
- → Supplementary Figure 2 from Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2023)